#NewMember | "AseBio is both the place to meet other companies in the industry and the voi... 29/09/2022 Access to innovation Innovative drugs Meet Affirma Biotech, our new member. We talked to Maribel Berges, CEO of the company. AseBio - AFFIRMA BIOTECH
Minoryx presenta la solicitud de autorización de comercialización de su fármaco leriglita... 14/09/2022 Access to innovation Innovative drugs Corporate La adrenoleucodistrofia ligada al cromosoma X (X-ALD) es una enfermedad minoritaria y neurodegenerativa para la cual no... Partners - Minoryx Therapeutics
#NewMemberAseBio | "AseBio is the door to the networking with key relevant stakeholders in... 12/09/2022 Healthcare Access to innovation In vitro diagnostics Meet MIMARK Diagnostics, S.L., our new member. We talked to Marina Rigau, CEO and founder of the company. AseBio - MiMARK diagnostics
BIOLAN revalidates its AOAC cetification for histamine quantification 08/09/2022 Access to innovation Corporate BIOLAN renews the Performance Tested Method PTM AOAC 051604 certificate for the quantification of histamine... Partners - Biolan
La inteligencia Artificial: Un reto para la Propiedad Intelectual 06/09/2022 Access to innovation La Inteligencia Artificial está cambiando el mundo en el que vivimos y se encuentra presente en casi todos los sectores... Partners - Elzaburu
BioTica Hotel Barceló, San José Costa Rirca Del 08/09/2022 08:00 to 08/09/2022 17:00 Access to innovation Bioeconomy
BTI leads the scientific production of Spanish bio-companies for the seventh consecutive y... 07/07/2022 Access to innovation Corporate This is the seventh consecutive year that the Vitoria-based biotech company has been ranked number one in scientific... Partners - BTI Biotechnology Institute
Natac successfully acquires INOREAL to expand their saffron natural product portfolio 21/06/2022 Healthcare Access to innovation International Communication Corporate Natac is dedicated to investigate, develop and sustainably manufacture plant extracts and compounds of natural origin... Partners - Natac Group
Sanofi-GSK next-generation COVID-19 booster delivers strong immune response against varian... 15/06/2022 Access to innovation Drug discovery Innovative drugs Next-generation booster vaccine candidate delivers immune boost in adults primed with mRNA vaccines; with a stronger... Partners - SANOFI
